Tammuella Chrisentery-Singleton
Pediatric Hematology-Oncology · New Orleans, LANPI 1710900758
Payments from drug & device makers
Across 1,375 payments — averaging $1579.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$471K
- Novo Nordisk$333K
- Genentech USA, Inc.$259K
- HEMA Biologics, LLC$179K
- CSL Behring$150K
- Pfizer$140K
- plus $639K from 26 others
Across 8 payments — averaging $1367.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 16 | $471,377 |
| Novo Nordisk | 185 | $333,254 |
| Genentech USA, Inc. | 162 | $258,971 |
| HEMA Biologics, LLC | 184 | $179,111 |
| CSL Behring | 110 | $150,428 |
| Pfizer | 40 | $139,716 |
| Sanofi | 81 | $136,949 |
| Kedrion Biopharma, Inc. | 22 | $131,738 |
| Shire North American Group Inc | 126 | $121,332 |
| Biomarin Pharmaceutical Inc. | 69 | $64,794 |
| Takeda Pharmaceuticals U.S.A., Inc. | 44 | $48,540 |
| Octapharma USA, Inc. | 42 | $26,917 |
| Novo Nordisk AS | 200 | $24,133 |
| Global Blood Therapeutics, Inc. | 37 | $19,022 |
| Kedrion Biopharma Inc. | 4 | $16,100 |
| F. Hoffmann-la Roche AG | 4 | $15,612 |
| Spark Therapeutics, Inc. | 13 | $12,594 |
| Bioverativ Therapeutics Inc. | 5 | $6,842 |
| Novo Nordisk Health Care AG | 6 | $6,133 |
| Bayer | 8 | $5,412 |
| Grifols USA, LLC | 1 | $2,800 |
| Viiv Healthcare Company | 1 | $105 |
| Novartis | 3 | $58 |
| Medexus Pharma, Inc. | 3 | $58 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| USWM, LLC | 1 | $27 |
| Amgen | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Day One Biopharmaceuticals | 1 | $19 |
| Chiesi USA, Inc. | 1 | $13 |
| Emmaus Medical, Inc. | 1 | $5 |
How this compares
$2,172,165 in reported general payments places this provider in the 95th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Maria Velez-YanguasNew Orleans$396K
- Lolie YuNew Orleans$283K
- Craig LottermanNew Orleans$211K
- Zachary LeblancNew Orleans$77K
- Renee GardnerNew Orleans$46K
- Robert VasquezNew Orleans$45K
- Dana LeblancNew Orleans$38K
- Pinki PrasadNew Orleans$20K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.